| Alexiou ZW, Hoenderboom BM, Hoebe CJPA, Dukers-Muijrers NHTM, Götz HM, van der Sande MAB, de Vries HJC, den Hartog JE, Morré SA, van Benthem BHB. Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022. Lancet Reg Health Eur. 2024 Aug 17;45:101027. doi: 10.1016/j.lanepe.2024.101027. PMCID: PMC11378087. |
| Alexiou ZW, Hoenderboom BM, Hoebe CJPA, Dukers-Muijrers NHTM, Götz HM, van der Sande MAB, de Vries HJC, den Hartog JE, Morré SA, van Benthem BHB. The importance of understanding pelvic inflammatory disease as a polymicrobial infection – authors’ reply. Lancet Reg Health Eur. 2024 Oct 30;47:101116. doi: 10.1016/j.lanepe.2024.101116. PMCID: PMC11554624. |
| Begré L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, Béguelin C, Rockstroh JK, Günthard HF, Calmy A, Cavassini M, Stöckle M, Schmid P, Bernasconi E, Levrero M, Zoulim F, Wandeler G, Rauch A; Swiss HIV Cohort Study (SHCS). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med. 2024 Feb;25(2):291-298. doi: 10.1111/hiv.13561. Epub 2023 Oct 10. |
| Begré L, Boyd A, Plissonnier ML, Testoni B, Salazar-Vizcaya L, Suter-Riniker F, Scholtès C, Béguelin C, Rockstroh JK, Günthard HF, Calmy A, Cavassini M, Hirsch HH, Schmid P, Bernasconi E, Levrero M, Wandeler G, Zoulim F, Rauch A; Swiss HIV Cohort Study. Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy. J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093/infdis/jiae189. Epub ahead of print. |
| Bermejo-Jambrina M, van der Donk LE, van Hamme JL, Wilflingseder D, de Bree G, Prins M, de Jong M, Nieuwkerk P, van Gils MJ, Kootstra NA, Geijtenbeek TB. Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies. EMBO J. 2024 Feb 28. doi: 10.1038/s44318-024-00061-0. Epub ahead of print. |
| Bolijn R, Spijkerman AMW, Galenkamp H, Blokstra A, Coyer L, Boyd A, Prins M, Stronks K. Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study. PLoS One. 2024 Oct 8;19(10):e0311196. doi: 10.1371/journal.pone.0311196. PMCID: PMC11460694. |
| Boyd A, Mathieu P, Françoise U, Rougier H, Chiarabini T, Valin N, Lacombe K, Woerther PL, Surgers L. Sexual behaviors and risk of extended-spectrum β-lactamase-producing Enterobacterales carriage: A cross-sectional analysis. Int J Infect Dis. 2024 Dec;149:107277. doi: 10.1016/j.ijid.2024.107277. Epub 2024 Oct 23. |
| Busch V, Steenkamer I, van Nassau F, van Opdorp P, van Houtum L, Verhoeff A, Twisk J. The Effects of the Jump-In Whole-School Intervention on the Weight Development of Children in Amsterdam, the Netherlands. J Sch Health. 2024 Jan;94(1):37-46. doi: 10.1111/josh.13363. Epub 2023 Jul 30. |
| Carrico AW, Ewart LD, Davidovich U, Maher L, Jonas KJ, Horvath KJ, Hirshfield S, Guadamuz TE, Carney T, Grov C. Responding to the global epidemic of amphetamine-type stimulant use compromising biomedical HIV prevention among men who have sex with men. Lancet HIV. 2024 Jun;11(6):e350-e352. doi: 10.1016/S2352-3018(24)00086-9. |
| Cespedes MS, Das M, Yager J, Prins M, Krznaric I, de Jong J, Xiao D, Shao Y, Wong P, Kintu A, Carter C, Hoornenborg E, Ruane P, Phoenix J, Younis I, Halperin J. Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial. Transgend Health. 2024 Jan 31;9(1):46-52. doi: 10.1089/trgh.2022.0048. PMCID: PMC10835152. |
| Concincion S, van Houtum L, van de Vorst B, Verhoeff A, Dedding C. Obesity care for youth during the COVID-19 pandemic: Challenges youth healthcare nurses experienced in providing obesity care in the Netherlands. Nurs Health Sci. 2024 Mar;26(1):e13084. doi: 10.1111/nhs.13084. |
| Concincion S, van Houtum L, Verhoeff A, Dedding C. Bored, afraid, alone: What can we learn from children with paediatric obesity about the impact of the COVID-19 pandemic for future pandemics, care practices and policies? J Pediatr Nurs. 2024 Mar 23;77:162-171. doi: 10.1016/j.pedn.2024.03.025. Epub ahead of print. |
| Concincion S, Dedding C, Verhoeff A, van Houtum L. Building space for children’s voices: The added value of participatory and creative approaches for child-centred integrated obesity care. J Pediatr Nurs. 2024 Nov-Dec;79:e223-e231. doi: 10.1016/j.pedn.2024.10.025. Epub 2024 Oct 28. PMID: 39490280. |
| de Jong SPJ, Felix Garza ZC, Gibson JC, van Leeuwen S, de Vries RP, Boons GJ, van Hoesel M, de Haan K, van Groeningen LE, Hulme KD, van Willigen HDG, Wynberg E, de Bree GJ, Matser A, Bakker M, van der Hoek L, Prins M, Kootstra NA, Eggink D, Nichols BE, Han AX, de Jong MD, Russell CA. Determinants of epidemic size and the impacts of lulls in seasonal influenza virus circulation. Nat Commun. 2024 Jan 18;15(1):591. doi: 10.1038/s41467-023-44668-z. PMCID: PMC10796432. |
| den Boogert EM, van Aar F, Heijne JCM. Investigating possibilities for surveillance of long term chlamydia complications in the Netherlands: A qualitative study. PLoS One. 2024 Jun 11;19(6):e0305279. doi: 10.1371/journal.pone.0305279. PMCID: PMC11166304. |
| de Oliveira Bressane Lima P, van de Kassteele J, Schipper M, Smorenburg N, S van Rooijen M, Heijne J, D van Gaalen R. Automating COVID-19 epidemiological situation reports based on multiple data sources, the Netherlands, 2020 to 2023. Comput Methods Programs Biomed. 2024 Sep 20;257:108436. doi: 10.1016/j.cmpb.2024.108436. Epub ahead of print. |
| Dias Gonçalves Lima F, Rozemeijer K, van der Zee RP, Dick S, Ter Braak TJ, Geijsen DE, Meijnen P, Lissenberg-Witte BI, van Noesel CJM, de Vries HJC, Prins JM, Steenbergen RDM. DNA methylation analysis on anal swabs for anal cancer screening in people living with HIV. J Infect Dis. 2024 Dec 24:jiae627. doi: 10.1093/infdis/jiae627. Epub ahead of print. |
| Drouin N, Elfrink HL, Boers SA, van Hugten S, Wessels E, de Vries JJC, Groeneveld GH, Miggiels P, Van Puyvelde B, Dhaenens M, Budding AE, Ran L, Masius R, Takats Z, Boogaerds A, Bulters M, Muurlink W, Oostvogel P, Harms AC, van der Lubben M, Hankemeier T. A Targeted LC-MRM3 Proteomic Approach for the Diagnosis of SARS-CoV-2 Infection in Nasopharyngeal Swabs. Mol Cell Proteomics. 2024 Jul;23(7):100805. doi: 10.1016/j.mcpro.2024.100805. Epub 2024 Jun 17. PMCID: PMC11284538. |
| Hage K, Boyd A, Op de Coul ELM, Sarink D, Hoornenborg E, Prins M. Hepatitis C virus infection is uncommon at baseline and during follow-up among individuals using PrEP in the Dutch national PrEP programme between 2019 and 2022. Sex Transm Infect. 2024 Jun 24:sextrans-2024-056169. doi: 10.1136/sextrans-2024-056169. Epub ahead of print. |
| Harney BL, Sacks-Davis R, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS. Hepatitis C virus reinfection incidence among gay and bisexual men with HIV in Australia from 2016 to 2020. Liver Int. 2024 Jan 31. doi: 10.1111/liv.15841. Epub ahead of print. |
| Harney BL, Sacks-Davis R, Agius P, van Santen DK, Traeger MW, Wilkinson AL, Asselin J, Fairley CK, Roth N, Bloch M, Matthews GV, Donovan B, Guy R, Stoové M, Hellard ME, Doyle JS. Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020. Open Forum Infect Dis. 2024 Feb 19;11(4):ofae099. doi: 10.1093/ofid/ofae099; PMCID: PMC10977630. |
| Haverkate MR, Willemstein IJ, van Ewijk CE, Adam PC, Lanooij SJ, Jonker-Jorna P, van Bokhoven C, van Rijckevorsel GG, Hoornenborg E, David S, Mollema L, Te Wierik MJ, Lange J, Franz E, de Melker HE, Op de Coul EL, Hahné SJ. Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023. Euro Surveill. 2024 May;29(21):2300608. doi: 10.2807/1560-7917.ES.2024.29.21.2300608. PMCID: PMC11128738. |
| de Jong M, van der Loeff MFS, Schilperoort R, Vennema H, van der Weijden C, Langeveld J, Welkers M, Prins M, de Roda Husman AM, Fanoy E, Medema G. Use of passive samplers as sewage surveillance tool to monitor a hepatitis A outbreak at a school in Amsterdam, the Netherlands, Oct 2022 – March 2023. BMC Infect Dis. 2024 Sep 27;24(1):1044. doi: 10.1186/s12879-024-09938-1. PMCID: PMC11430438. |
| Jongen VW, van Dongen N, Sohn AH. Human papillomavirus infection among adolescents living with HIV: a focus on prevention. Curr Opin HIV AIDS. 2024 Jun 20. doi: 10.1097/COH.0000000000000868. Epub ahead of print. |
| Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJG, van der Valk M, Reiss P, Prins M, Hoornenborg E; ATHENA observational HIV cohort. Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands’ ATHENA observational cohort. J Int AIDS Soc. 2024 Aug;27(8):e26317. doi: 10.1002/jia2.26317. PMCID: PMC11310271. |
| Kerkhof MPJ, Lefevre ER, de Mast Q. Een nieuw denguevaccin voor reizigers. TIJDSCHR INFECT 2024;19(2):61–5 |
| Kolodziej LM, Paap KC, van Buul LW, Kuil SD, Hertogh CMPM, de Jong MD. Influence of the COVID-19 Pandemic on Influenza and SARS-CoV-2 Vaccination Willingness Among Dutch Nursing Home Health Care Workers. J Am Med Dir Assoc. 2024 Dec 27;26(2):105420. doi: 10.1016/j.jamda.2024.105420. Epub ahead of print. |
| Kullberg RFJ, Wikki I, Haak BW, Kauko A, Galenkamp H, Peters-Sengers H, Butler JM, Havulinna AS, Palmu J, McDonald D, Benchraka C, Abdel-Aziz MI, Prins M, Maitland van der Zee AH, van den Born BJ, Jousilahti P, de Vos WM, Salomaa V, Knight R, Lahti L, Nieuwdorp M, Niiranen T, Wiersinga WJ. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies. Lancet Microbe. 2024 Sep;5(9):100864. doi: 10.1016/S2666-5247(24)00079-X. Epub 2024 Jun 20. |
| Kusters JMA, Obels I, van der Klis FRM, King AJ, Heijman T, Heijne JCM, van Benthem BHB; PASSYON study group; van der Loeff MFS. Prevalence and risk factors for HPV seropositivity and anogenital DNA positivity among men who have sex with men: a repeated cross-sectional study. Int J Infect Dis. 2024 May 20;145:107094. doi: 10.1016/j.ijid.2024.107094. Epub ahead of print. |
| Kusters JMA, Schim van der Loeff MF, Heijne JCM, King AJ, de Melker HE, Heijman T, Bogaards JA, van Benthem BHB. Changes in Genital HPV Prevalence during 12 Years Girls-Only Bivalent HPV Vaccination: Results from a Biennial Repeated Cross-Sectional Study. J Infect Dis. 2024 Sep 13:jiae455. doi: 10.1093/infdis/jiae455. Epub ahead of print. |
| Kusters JMA, van der Loeff MFS, van Benthem BHB, King AJ; PASSYON study group; de Melker HE, Heijman T, Heijne JCM. Effectiveness of bivalent HPV vaccination against genital HPV DNA-positivity of a catch-up campaign at age 13-16 years compared to routine vaccination at age 12 years: a biennial repeated cross-sectional study. BMC Med. 2024 Oct 15;22(1):469. doi: 10.1186/s12916-024-03686-4. PMCID: PMC11475922. |
| Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R; Global F/TDF PrEP Study Team. HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093/cid/ciae143. Epub ahead of print. |
| Loef B, Boer JMA, Beekman M, Campman SL, Hoogendijk EO, Huider F, Pagen DME, Splinter MJ, van der Velde JHPM, Boomsma DI, Dagnelie PC, van Dongen J, de Geus EJC, Huisman M, Ikram MA, Koster A, Licher S, Mierau JO, de Mutsert R, Picavet HSJ, Rosendaal FR, Schram MT, Slagboom PE, van der Spoel E, Stronks K, Verschuren WMM, van den Berg SW; Lifelines Corona Research initiative. The association of overweight, obesity, and long-term obesity with SARS-CoV-2 infection: a meta-analysis of 9 population-based cohorts from the Netherlands Cohorts Consortium. Int J Obes (Lond). 2024 Oct 31. doi: 10.1038/s41366-024-01660-x. Epub ahead of print. |
| McGuinness SL, Veit O, Angelin M, Antonini P, Boecken G, Boering M, Bühler S, Calleri G, Éperon G, Flaherty G, Gossner C, Askling HH, Holmberg V, Kuenzli E, Landry P, Lefevre E, Libman M, Longley N, Maniewski-Kelner U, Neumayr A, Rapp C, Ridpath AD, Rodriguez N, Rosdahl A, Rosenbusch D, Rossanese A, Rothe C, Schlagenhauf P, Soentjens P, Staehelin C, Visser J, Visser L, Wagner A, Walker A, Wiedermann U, Wroczynska A, Hatz C. Streamlining malaria prevention recommendations for travellers: current and future approaches. J Travel Med. 2024 Aug 21:taae113. doi: 10.1093/jtm/taae113. Epub ahead of print. |
| Meyer L, Schim van der Loeff MF. Sexually transmitted infections in the preexposure prophylaxis era. AIDS. 2024 Jun 1;38(7):1085-1086. doi: 10.1097/QAD.0000000000003872. Epub 2024 May 1. |
| Miura F, Backer JA, van Rijckevorsel G, Bavalia R, Raven S, Petrignani M, Ainslie KEC, Wallinga J; Dutch Mpox Response Team. Time Scales of Human Mpox Transmission in The Netherlands.. J Infect Dis. 2024 Mar 14;229(3):800-804. doi: 10.1093/infdis/jiad091. PMCID: PMC10938196. |
| Mohareb AM, Kim AY, Boyd A, Noubary F, Kouamé MG, Anglaret X, Coffie PA, Eholie SP, Freedberg KA, Hyle EP. Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 2024 Jan 12;14(1):e073498. doi: 10.1136/bmjopen-2023-073498. PMCID: PMC10806737. |
| Mohareb AM, Kouamé MG, Nouaman M, Kim AY, Larmarange J, Neilan AM, Lacombe K, Freedberg KA, Boyd A, Coffie P, Hyle EP. What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic? J Int AIDS Soc. 2024 Mar;27(3):e26218. doi: 10.1002/jia2.26218. PMCID: PMC10935702. |
| Nieuwenburg SA, Jongen VW, Schim van der Loeff M, de Vries H, van Dam A. Seroconversion in syphilis screening without positive confirmatory tests points at early infection. Sex Transm Infect. 2024 Jan 22:sextrans-2023-055973. doi: 10.1136/sextrans-2023-055973. |
| Nieuwenburg SA, Bruisten SM, Heijman T, Vermeulen W, van Dam AP, Schim van der Loeff MF, de Vries HJC. Use of home-based self-collected dried blood spots to test for syphilis, HIV, hepatitis C and B virus infections and measuring creatinine concentration. Sex Transm Dis. 2024 Mar 2. doi: 10.1097/OLQ.0000000000001941. Epub ahead of print. |
| Nieuwenburg SA, van Bijnen A, Vermey K, Stam A, Zuilhof W, Hoornenborg E, Schim van der Loeff MF, de Vries HJC. Do men who have sex with men recognise syphilis symptoms? A syphilis awareness campaign in Amsterdam, the Netherlands. Sex Transm Infect. 2024 Jul 25:sextrans-2023-055925. doi: 10.1136/sextrans-2023-055925. Epub ahead of print. |
| Pantazis N, Sabin CA, Grabar S, Van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K; CASCADE Collaboration [Davidovich Udi]. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration. Lancet HIV. 2024 Oct;11(10):e660-e669. doi: 10.1016/S2352-3018(24)00183-8. Epub 2024 Aug 23. PMID: 39186940. |
| Reitsema M, Wallinga J, van Sighem AI, Bezemer D, van der Valk M, van Aar F, Maria Heijne JC, Hoornenborg E, Rozhnova G, van Benthem B, Xiridou M. Impact of varying pre-exposure prophylaxis programs on HIV and Neisseria gonorrhoeae transmission among MSM in the Netherlands: a modelling study. J Acquir Immune Defic Syndr. 2024 Aug 22. doi: 10.1097/QAI.0000000000003511. Epub ahead of print. |
| Requena MB, Protopopescu C, Stewart AC, van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; InCHEHC Collaboration. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. Int J Drug Policy. 2024 Jan 6;124:104311. doi: 10.1016/j.drugpo.2023.104311. Epub ahead of print. |
| Rotsaert A, Smekens T, Jaminé D, Di Zinno T, Deblonde J, Lambert ML, Florence E, Reyniers T, Vanhamel J, Lucet C, van der Loeff MS, Hensen B, Vuylsteke B. Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019. BMC Public Health. 2024 Aug 23;24(1):2296. doi: 10.1186/s12889-024-19691-4. PMCID: PMC11342504. |
| Rozemeijer K, Dias Gonçalves Lima F, Ter Braak TJ, Hesselink AT, Prins JM, de Vries HJC, Steenbergen RDM. Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer. Tumour Virus Res. 2024 Jun;17:200275. doi: 10.1016/j.tvr.2023.200275. Epub 2023 Dec 30. PMCID: PMC10821616. |
| Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Lancet HIV. 2024 Feb;11(2):e106-e116. doi: 10.1016/S2352-3018(23)00267-9. Epub 2024 Jan 12. |
| Schönnesson LN, Cluver L, Eriksson LE, Davidovich U, Harding R, Spire B, Catalan J, Karkouri M, Steventon-Roberts K, Prince B, Sherr L. The power for action – now! AIDS Care. 2024 May 9:1-5. doi: 10.1080/09540121.2024.2321697. Epub ahead of print. |
| Schuele L, Boter M, Nieuwenhuijse DF, Götz H, Fanoy E, de Vries H, Vieyra B, Bavalia R, Hoornenborg E, Molenkamp R, Jonges M, van den Ouden A, Simões M, van den Lubben M, Koopmans M, Welkers MRA, Oude Munnink BB. Circulation, viral diversity and genomic rearrangement in mpox virus in the Netherlands during the 2022 outbreak and beyond. J Med Virol. 2024 Jan;96(1):e29397. doi: 10.1002/jmv.29397. |
| Sechan F, Edridge AWD, van Rijswijk J, Jebbink MF, Deijs M, Bakker M, Matser A, Prins M, van der Hoek L. Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections. Microbiol Spectr. 2024 Feb 8:e0391223. doi: 10.1128/spectrum.03912-23. Epub ahead of print. |
| Shamier MC, Zaeck LM, Götz HM, Vieyra B, Verstrepen BE, Wijnans K, Welkers MR, Hoornenborg E, van Cleef BA, van Royen ME, Jonas KJ, Koopmans MP, de Vries RD, van de Vijver DA, GeurtsvanKessel CH. Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022. Euro Surveill. 2024 Apr;29(17):2300532. doi: 10.2807/1560-7917.ES.2024.29.17.2300532. PMCID: PMC11063670. |
| Sluimer J, van den Akker WMR, Goderski G, Swart A, van der Veer B, Cremer J, Chung NH, Molenkamp R, Voermans J, Guldemeester J; Working Group SARS-CoV-2 Diagnostics The Netherlands; Eggink D, Presser LD, Meijer A. High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment. Sci Rep. 2024 Jan 16;14(1):1378. doi: 10.1038/s41598-023-50912-9. PMCID: PMC10792020. |
| Teker B, Schim van der Loeff M, Hoornenborg E, Boyd A, Reedijk S, van Dam A, Jongen VW, de Vries H. Minimum inhibitory concentrations of Neisseria gonorrhoeae strains in clients of the Amsterdam sexual health clinic with a Dutch versus an international sexual network. Sex Transm Infect. 2024 Apr 18;100(3):173-180. doi: 10.1136/sextrans-2023-055988. |
| Stam AJ, Buchholtz NVEJ, Bierman WFW, van Crevel R, Hoepelman AIM, Claassen MAA, Ammerlaan HSM, van Welzen BJ, van Kasteren MEE, van Lelyveld SFL, de Jong D, Tesselaar K, van Luin M, Nijhuis M, Wensing AMJ, Lowerit Study Team. Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen. Viruses. 2024 Jan 25;16(2):182. doi: 10.3390/v16020182. PMCID: PMC10893305. |
| Stam AJ, Groenewegen H, Vissink A, Wensing AMJ, Nijhuis M, Bierman WFW. Periodontal inflammation as a potential driver of HIV low level viremia. PLoS One. 2024 Jun 17;19(6):e0305641. doi: 10.1371/journal.pone.0305641. PMCID: PMC11182545. |
| Teijema MT, van der Meij LLM, de Groot SM, Hoogerbrugge A, Hoornenborg E. Towards zero new HIV infections in Amsterdam in 2026; building bridges between community organizations, undocumented migrants and sexual healthcare providers. Sex Transm Dis. 2024 Jul 18. doi: 10.1097/OLQ.0000000000002041. Epub ahead of print. |
| Teker B, Schim van der Loeff MF, Boyd A, Hoornenborg E, Stam AJ, de Vries HJC, Jongen VW. Increase in Neisseria gonorrhoeae infections after ending COVID-19 lockdown measures in Amsterdam, the Netherlands. Sex Transm Infect. 2024 Dec 6:sextrans-2024-056276. doi: 10.1136/sextrans-2024-056276. Epub ahead of print. |
| Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group: Scientific oversight and coordination; Data management; Statistical support; Central laboratory support; Project management and administrative support; Participating HIV physicians and nurses:; Other collaborators:. A biomarker profile reflective of preserved thymic function is associated with reduced comorbidities in ageing people with HIV: an AGEhIV Cohort analysis. J Infect Dis. 2024 Dec 10:jiae603. doi: 10.1093/infdis/jiae603. Epub ahead of print. |
| van de Kerkhof MPJ, Lefevre ER, de Mast Q. A new dengue vaccine for travelers. TVI (Tijdschrift voor Infectieziekten); Jaargang 19; mei 2024 |
| van den Elshout MAM, Wijstma ES, Boyd A, Jongen VW, Coyer L, Anderson PL, Davidovich U, de Vries HJC, Prins M, Schim van der Loeff MF, Hoornenborg E; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM). Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. PMCID: PMC11111007. |
| Van den End Sanne, van Ewijk Katja, Keur Ingrid, Boreel Jaap, van Cleef Brigitte, Eblé Phaedra, van Rijckevorstel Gini, te Wierik Margreet Gedeeld eerste auteurschap; correspondentie naar s.vandenend@nvwa.nl TIJDSCHRIFT VOOR DIERGENEESKUNDE Jaargang 149, aflevering 9, september 2024 https://www.knmvd.nl/rabies-in-nederland-twee-casussen-met-veterinaire-en-humane-dilemmas/ zie ook als bijlage U schijf Publicaties, 2024, artikelen |
| van der Zalm MM, Jongen VW, Swanepoel R, Zimri K, Allwood B, Palmer M, Dunbar R, Goussard P, Schaaf HS, Hesseling AC, Seddon JA. Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion. EClinicalMedicine. 2024 Jan 3;67:102406. doi: 10.1016/j.eclinm.2023.102406. PMCID: PMC10796966. |
| van Dijk M, Boyd A, Brakenhoff SM, Isfordink CJ, van Zoest RA, Verhagen MD, de Knegt RJ, Drenth JPH, van der Valk M; HepNed study group. Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study. Liver Int. 2024 Jan;44(1):52-60. doi: 10.1111/liv.15729. Epub 2023 Sep 17. |
| van der Loo CHM, Schim van der Loeff R, Martín A, Gomez-Sal P, Borst MLG, Pouwer K, Minnaard AJ. Correction: π-Facial selectivity in the Diels-Alder reaction of glucosamine-based chiral furans and maleimides. Org Biomol Chem. 2024 Jan 3;22(2):395-397. doi: 10.1039/d3ob90168h. Erratum for: Org Biomol Chem. 2023 Mar 1;21(9):1888-1894. |
| van Santen DK, Stewart A, Doyle JS, Stoové MA, Asselin J, Klein MB, Young J, Berenguer J, Jarrin I, Lacombe K, Wittkop L, Leleux O, Salmon D, Bonnet F, Rauch A, Mugglin C, Matthews G, Prins M, Smit C, Boyd A, van der Valk M, Sacks-Davis R, Hellard ME; InCHEHC Study Group. Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). Int J Epidemiol. 2024 Feb 1;53(1):dyad154. doi: 10.1093/ije/dyad154.; PMCID: PMC10859136. |
| van Wees D, Coyer L, van den Elshout M, de Coul EO, van Aar F. The Best Predictor of Future Behavior May Be the Past: Exploring Behavior Change in Men Who Have Sex with Men Using Pre-exposure Prophylaxis in the Netherlands. Arch Sex Behav. 2024 May 6. doi: 10.1007/s10508-024-02863-z. Epub ahead of print. |
| Veit O, Maniewski U, Rothe C, Eperon G, Boering M, Alcedo S, Boecken G, Ramharter M, Schel N, Soentjens P, Staehelin C, van Vugt M, Weitzel T, Visser LG, Schlagenhauf P, Hatz C, Neumayr A; malaria working groups (listed at the end). Methodology of the joint malaria prevention recommendations of Switzerland, Germany, Belgium, and the Netherlands. J Travel Med. 2024 Sep 26:taae129. doi: 10.1093/jtm/taae129. Epub ahead of print. |
| Verveen A, Verfaillie SCJ, Visser D, Koch DW, Verwijk E, Geurtsen GJ, Roor J, Appelman B, Boellaard R, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, van Berckel B, Tolboom N, Knoop H. Neuropsychological functioning after COVID-19: minor differences between individuals with and without persistent complaints after SARS-CoV-2 infection. Clin Neuropsychol. 2024 Jul 17:1-16. doi: 10.1080/13854046.2024.2379508. Epub ahead of print. |
| Verveen A, Nugroho FA, Bucur IG, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, de Bree GJ, de Jong MD, Kootstra N, Claassen T, de Jonge MI, Heskes T, Prins M, Knoop H, Nieuwkerk PT; RECoVERED Study Group. Long-term sequelae of SARS-CoV-2 two years following infection: exploring the interplay of biological, psychological, and social factors. Psychol Med. 2024 Dec 2:1-11. doi: 10.1017/S0033291724002721. Epub ahead of print. |
| Verburgh ML, Boyd A, Schim van der Loeff MF, Bakker M, Wit FWNM, van der Valk M, Grobben M, van Pul L, Tejjani K, van Rijswijk J, van Gils MJ, Kootstra NA, van der Hoek L, Reiss P; AGEhIV Cohort Study. Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls. Open Forum Infect Dis. 2024 Jul 8;11(7):ofae380. doi: 10.1093/ofid/ofae380. PMCID: PMC11273239. |
| Vink M, Coppoolse H, Bergmans A, Wennekes M, Pas S, Pattipeilohy-van Ommen J, Braks M, Bruisten S, Galimont-Collen A, Wintermans B, Fanoy E. Exploring transmission dynamics of the Sarcoptes scabiei mite in humans by combining molecular typing and epidemiological variables, the Netherlands 2016-2023. Parasit Vectors. 2024 Oct 7;17(1):419. doi: 10.1186/s13071-024-06488-y. PMCID: PMC11459799. |
| Visser M, Hoebe CJPA, Wolffs PFG, Heijne JCM. Anorectal Neisseria gonorrhoeae infections in women with an3840461d without reported anal sex and sex workers in sexual health centres in the Netherlands: a retrospective cohort study. Lancet Microbe. 2024 Feb 12:S2666-5247(23)00376-2. doi: 10.1016/S2666-5247(23)00376-2. Epub ahead of print. |
| Visser M, Hoebe CJPA, Wolffs PFG, Heijne JCM. Rectal gonorrhoea in women: true infections?-Authors’ reply. Lancet Microbe. 2024 Jul 19:100932. doi: 10.1016/S2666-5247(24)00174-5. Epub ahead of print. |
| Vogels CBF, Hill V, Breban MI, Chaguza C, Paul LM, Sodeinde A, Taylor-Salmon E, Ott IM, Petrone ME, Dijk D, Jonges M, Welkers MRA, Locksmith T, Dong Y, Tarigopula N, Tekin O, Schmedes S, Bunch S, Cano N, Jaber R, Panzera C, Stryker I, Vergara J, Zimler R, Kopp E, Heberlein L, Herzog KS, Fauver JR, Morrison AM, Michael SF, Grubaugh ND. DengueSeq: a pan-serotype whole genome amplicon sequencing protocol for dengue virus. BMC Genomics. 2024 May 1;25(1):433. doi: 10.1186/s12864-024-10350-x.PMCID: PMC11062901. |
| Wahome E, Otieno FO, Kimani J, Boyd A, Okall D, Nzioka J, Gichuru E, van der Elst E, Mehta SD, Bailey RC, Graham SM, Sanders EJ; for the Tatu Pamoja (three-site) study group. Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya. AIDS. 2024 Mar 1;38(3):407-413. doi: 10.1097/QAD.0000000000003782. Epub 2023 Nov 27. PMCID: PMC10842664. |
| Wei F, Gaisa MM, D’Souza G, Xia N, Giuliano AR, Hawes SE, Gao L, Cheng SH, Donà MG, Goldstone SE, Schim van der Loeff MF, Neukam K, Meites E, Poynten IM, Dai J, Combes JD, Wieland U, Burgos J, Wilkin TJ, Hernandez AL, Iribarren Díaz M, Hidalgo-Tenorio C, Valencia Arredondo M, Nyitray AG, Wentzensen N, Chow EP, Smelov V, Nowak RG, Phanuphak N, Woo YL, Choi Y, Hu Y, Schofield AM, Woestenberg PJ, Chikandiwa AT, Hickey AC, de Pokomandy A, Murenzi G, Péré H, Del Pino M, Ortiz AP, Charnot-Katsikas A, Liu X, Chariyalertsak S, Strong C, Ong JJ, Yunihastuti E, Etienney I, Ferré VM, Zou H, Segondy M, Chinyowa S, Alberts CJ, Clifford GM. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. Lancet HIV. 2021 Sep;8(9):e531-e543. doi: 10.1016/S2352-3018(21)00108-9. Epub 2021 Jul 30. PMCID: PMC8408042. |
| Wehrli S, Irrgang C, Scott M, Arnrich B, Boender TS. The role of the (in)accessibility of social media data for infodemic management: a public health perspective on the situation in the European Union in March 2024. Front Public Health. 2024 Apr 8;12:1378412. doi: 10.3389/fpubh.2024.1378412. PMCID: PMC11033458. |
| Wijstma E, Jongen VW, Boyd A, de Vries HJC, Loeff MFSV, Prins M, Hoornenborg E. Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized PrEP care in Amsterdam, the Netherlands: a cross-sectional study. AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004027. Epub ahead of print. |
| Wijstma ES, Vanbellinghen MC, van der Loeff MFS. Treatment-as-prevention and HIV incidence in men who have sex with men. Lancet HIV. 2024 Apr;11(4):e207. doi: 10.1016/S2352-3018(24)00058-4. |
| Wijstma ES, Jongen VW, Boyd A, van den Elshout M, de Vries HJC, Davidovich U, Anderson PL, Prins M, Hoornenborg E, Schim van der Loeff MF. Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project. AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889. Epub ahead of print. |
| Wynberg E, Han AX, van Willigen HDG, Verveen A, van Pul L, Maurer I, van Leeuwen EM, van den Aardweg JG, de Jong MD, Nieuwkerk P, Prins M, Kootstra NA, de Bree GJ; RECoVERED Study Group. Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset: A prospective cohort study of individuals with mild to critical COVID-19. PLoS One. 2024 Jul 15;19(7):e0304990. doi: 10.1371/journal.pone.0304990.PMCID: PMC11249251. |
